Digi.bio helps to automate Laboratory Research [Sponsored]

//Digi.bio helps to automate Laboratory Research [Sponsored]

Digi.bio helps to automate Laboratory Research [Sponsored]

 

This video is sponsored content from the Accelerator Program of Merck learn more here: bit.ly/2rsFEUQ

In this interview, we talk to Federico Muffatto (https://www.linkedin.com/in/federico-muffatto-a30b715b/), who is the CEO of Digi.Bio (http://digi.bio/). Digi.Bio helps to automate research in the laboratory, which has, until now, required a lot of manual labor. Their system helps to automate research and mix liquids on their chip. Learn more in the video.

Digi.bio is part of the 2018 batch of the Merck Accelerator Program.

The Accelerator selects and support startups operating in healthcare, performance materials, life sciences, and other related business fields. They are looking for real partners to work together in shaping the future. From July until the end of September Merck (Or Merck KGaA Darmstadt, Germany) will be looking for startups to join their Accelerator Program in Darmstadt. You can go to their headquarters to connect with worldwide decision-makers and win them as a business partner. They also offer the possibility to extend the Accelerator in their Innovation Hub in China and succeed in accessing the Chinese market. You can apply now: bit.ly/2rsFEUQ.

The recording was conducted at Merck’s fancy new Innovation Center: https://www.merckgroup.com/en/research/innovation-center.html

 

TRANSCRIPT BELOW

 

By |2018-10-26T18:12:49+00:00August 8th, 2018|blog|0 Comments

About the Author:

Leave A Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.